Pier Lambiase, EHRA 2019 – Sudden Death Risk in Non-ischaemic Cardiomyopathy
Professor Pier Lambiase (Consultant Electrophysiologist, University College London and Barts Heart Centre, London, UK) joins touchCARDIO at the annual European Heart Rhythm (EHRA) 2019 congress in Lisbon to discuss the risks of sudden cardiac death and new techniques to improve prevention, diagnosis and monitoring.
Filmed at EHRA 2019, Lisbon.
Speaker’s Disclosures: Professor Pier Lambiase has received research grants from Abbott, Boston Scientific and Medtronic.
Questions:
- Sudden cardiac death remains a significant global healthcare concern – please explain its risk in patients with non-ischaemic cardiomyopathy. (0:14)
- How can patients with non-ischaemic cardiomyopathy be stratified to help assess risk and improve prevention of sudden cardiac death? (0:39)
- What imaging techniques can be employed to facilitate diagnosis and monitoring? (1:47)
- What are the key factors in improving prevention of sudden cardiac death in patients with non-ischaemic cardiomyopathy? (2:39)
- Please summarise your highlights of the EHRA 2019 congress so far. (3:24)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
